SEC Filings

Form Description Filing date View
10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
424B1

Form of prospectus that discloses information previously omitted from the prospectus

View HTML
10-Q/A

Amendment to a previously filed 10-Q

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
S-3

Simplified registration form

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
10-K405

Annual report. The Regulation S-K Item 405 box on the cover page is checked

View HTML

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline